Rasagiliinin ja essitalopraamin yhteiskäytön turvallisuus

Status

Active, not recruiting

Phases

Phase 1Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-004530-33-FI

Enrollment

Unknown

Registered

2006-08-14

Start date

2006-04-12

Completion date

Unknown

Last updated

2016-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

terveet vapaaehtoiset

Interventions

Trade Name: Azilect Product Name: Azilect Pharmaceutical Form: Tablet INN or Proposed INN: RASAGILINE CAS Number: 136236516 Trade Name: Cipralex Product Name: Cipralex Pharmaceutical Form: Tablet INN

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: terveet vapaaehtoiset Are the trial subjects under 18? Number of subjects for this age range: F.1.2 Adults (18-64 years) F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: Rasagiliilin ja essitalopraamin mahdolliset yhteisvaikutukset;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026